Return-Path: <josh@josh.is>
Received: from [10.34.53.200] ([213.220.122.141])
        by smtp.gmail.com with ESMTPSA id n14sm3419686wmi.33.2020.10.02.19.21.17
        for <hulda@simple.is>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Fri, 02 Oct 2020 19:21:17 -0700 (PDT)
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
From: Josh Klein <josh@josh.is>
Mime-Version: 1.0 (1.0)
Date: Sat, 3 Oct 2020 02:21:16 +0000
Subject: President Trump Received Regeneron Experimental Antibody Treatment - The New York Times
Message-Id: <BE9A1B3D-F3AF-40F0-8A1C-F05A8A8C9C9F@josh.is>
To: =?utf-8?Q?Hulda_Emilsd=C3=B3ttir?= <hulda@simple.is>
X-Mailer: iPhone Mail (17H35)

Your brothers theory may have some merit...

https://www.nytimes.com/2020/10/02/health/trump-antibody-treatment.html
